How Long Until Allergy Shots Work? Your Month-by-Month Guide

Yes — feeling slightly worse or unchanged during the first 4-8 weeks of allergy shots is completely normal and expected. Allergen-specific IgE levels can transiently rise during early build-up before the immune system begins shifting toward tolerance, a phenomenon documented by Gleich et al. (J Immunol 1982). Local injection site reactions are also common in 30-80% of patients and can include redness, swelling, and itching. Additionally, build-up injections do not contain enough allergen to trigger meaningful immune training yet — the doses are too low. If you feel significantly worse with systemic symptoms such as hives, wheezing, or generalized itching, contact your allergist — these may indicate a systemic reaction requiring dose adjustment.

Most patients notice the first meaningful improvement 3-6 months after reaching their maintenance dose. Because build-up typically takes 3-6 months, the total timeline from first injection to first improvement is often 6-12 months. The clearest sign that allergy shots are working is usually a better-than-expected allergy season — lower symptom scores and reduced need for rescue antihistamines compared to the same season before treatment. Patient-reported outcomes from Calderon et al. (Allergy 2007) show 85% of patients who complete one year of maintenance report improvement by 12 months, with medication use typically dropping 40-60% during the first effective treatment season.

Six months from your first injection is not enough time to evaluate whether allergy shots are working — at that point you have likely only recently reached or are still approaching maintenance dose. The clinical guideline for an 'adequate trial' is a minimum of one full year at the maintenance dose before concluding treatment failure (AAAAI/ACAAI Practice Parameter, Cox 2011). If you have been at maintenance for 12 or more months and see no improvement, your allergist should re-evaluate allergen selection, assess whether you are receiving adequate allergen doses, and review environmental controls. Approximately 10-20% of SCIT patients are non-responders, but premature discontinuation before 12 months on maintenance is the most common reason for apparent non-response.

Yes — seasonal allergens like grass pollen and ragweed often produce more noticeable early improvement because patients can directly compare their experience during a defined pollen season to their pre-treatment baseline. Perennial allergens like dust mites and pet dander produce gradual improvement that is harder to self-detect because exposure is continuous year-round. Cat dander SCIT typically takes longer (6-18 months to meaningful improvement) because continuous home allergen exposure partially counteracts desensitization. Evidence from Calderon et al. (Cochrane 2007) and Abramson et al. (Cochrane 2010) confirms that grass and dust mite SCIT produce statistically significant symptom reduction within 12 months of reaching maintenance in controlled trial settings.

Reducing antihistamine use is one of the first measurable signs that allergy shots are working, but your allergist should guide the timing of any reduction. Studies show antihistamine use typically drops 40-60% by the end of the first maintenance year (Durham et al., NEJM 1999), with some patients able to eliminate antihistamines entirely during pollen season by year two. However, many patients continue to use rescue antihistamines during peak allergy seasons even during active SCIT treatment, particularly in the first year when treatment benefit is still building. Tracking your antihistamine use as a diary metric is actually an excellent way to objectively measure whether your shots are working — a progressive reduction over time is a strong positive indicator.

Managing the waiting period requires realistic expectations, consistent tracking, and continued use of symptom management tools while treatment builds. Your allergist can continue prescribing antihistamines, nasal corticosteroids, and other medications during the build-up and early maintenance phases — immunotherapy does not require stopping all other treatments. Keeping a symptom diary helps you notice subtle early improvements you might otherwise miss, since the changes during the first 6-12 months are often gradual rather than dramatic. Psychological research on treatment adherence (Makatsori et al., Clin Transl Allergy 2014) confirms that patients who track their own progress and maintain realistic outcome expectations are significantly more likely to complete treatment — completion is the key variable in whether you ultimately benefit.